• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有格雷夫斯病的甲状腺激素抵抗。

Resistance to thyroid hormone accompanied by Graves' disease.

作者信息

Shiwa Tsuguka, Oki Kenji, Awaya Tomokazu, Nakanishi Shuhei, Yamane Kiminori

机构信息

Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Japan.

出版信息

Intern Med. 2011;50(18):1977-80. doi: 10.2169/internalmedicine.50.4904. Epub 2011 Sep 15.

DOI:10.2169/internalmedicine.50.4904
PMID:21921380
Abstract

Resistance to thyroid hormone (RTH) is characterized by elevated serum levels of thyroid hormones and normal or slightly increased serum thyrotropin (TSH) levels. Recently it has been suggested that chronic TSH stimulation in RTH activates intrathyroidal lymphocytes, leading to thyroid damage and autoimmune thyroid disease (AITD). Therefore, individuals with RTH have an increased likelihood of AITD compared to unaffected relatives. We here report a 33-year-old woman in whom we diagnosed Graves' disease and treated her with thiamazole (MMI). For two years, her TSH levels were suppressed when thyroid hormones were elevated and conversely they were increased when thyroid hormones levels were decreased. These findings were common for a clinical course during treatment for Graves' disease with anti-thyroid drug. However, three years after the initiation of MMI therapy, she had a normal or gradually elevated serum TSH level even though the level of thyroid hormones never decreased, indicating inappropriate secretion of TSH. We concluded she had RTH clinically, and we demonstrated by direct sequence analysis a mutation of the TRβ gene, causing replacement of a glycine (G) with arginine (R) at codon 251. The finding of an elevated TSH level without decreased thyroid hormones should suggest the presence of RTH during therapy of Graves' disease.

摘要

甲状腺激素抵抗(RTH)的特征是血清甲状腺激素水平升高,而血清促甲状腺激素(TSH)水平正常或略有升高。最近有人提出,RTH中的慢性TSH刺激会激活甲状腺内淋巴细胞,导致甲状腺损伤和自身免疫性甲状腺疾病(AITD)。因此,与未受影响的亲属相比,RTH患者患AITD的可能性增加。我们在此报告一名33岁女性,我们诊断其患有格雷夫斯病并用甲巯咪唑(MMI)对其进行治疗。两年来,当甲状腺激素升高时她的TSH水平受到抑制,反之,当甲状腺激素水平降低时TSH水平则升高。这些发现在用抗甲状腺药物治疗格雷夫斯病的临床过程中很常见。然而,在开始MMI治疗三年后,即使甲状腺激素水平从未降低,但她的血清TSH水平正常或逐渐升高,表明TSH分泌异常。我们临床诊断她患有RTH,并通过直接序列分析证实TRβ基因发生突变,导致第251密码子处的甘氨酸(G)被精氨酸(R)取代。在格雷夫斯病治疗期间,TSH水平升高而甲状腺激素水平未降低的情况应提示存在RTH。

相似文献

1
Resistance to thyroid hormone accompanied by Graves' disease.伴有格雷夫斯病的甲状腺激素抵抗。
Intern Med. 2011;50(18):1977-80. doi: 10.2169/internalmedicine.50.4904. Epub 2011 Sep 15.
2
Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T).格雷夫斯病混合甲状腺激素抵抗引起的原发性甲状腺功能亢进症的临床特征(P453T)。
Endocr J. 2010;57(8):687-92. doi: 10.1507/endocrj.k10e-066. Epub 2010 Jun 22.
3
Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.在 Graves 病患者中,使用甲巯咪唑进行抗甲状腺药物治疗时发生甲状腺功能减退症是一个有利的预后指标。
Thyroid. 2010 Sep;20(9):949-54. doi: 10.1089/thy.2009.0126.
4
Resistance to thyroid hormone in a patient with coexisting Graves' disease.合并 Graves 病患者的甲状腺激素抵抗
Thyroid. 2010 Feb;20(2):213-6. doi: 10.1089/thy.2009.0175.
5
Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.慢性碘给药对既往因格雷夫斯甲亢接受抗甲状腺药物治疗的甲状腺功能正常受试者甲状腺状态的影响。
J Clin Endocrinol Metab. 1993 Apr;76(4):928-32. doi: 10.1210/jcem.76.4.7682562.
6
Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.血清促甲状腺激素(TSH)水平持续受到抑制,可能归因于促甲状腺激素受体抗体活性、甲状腺毒症的严重程度以及接受治疗的甲状腺功能正常的格雷夫斯病患者甲状腺激素恢复所需的时间。
Thyroid. 2006 Dec;16(12):1251-7. doi: 10.1089/thy.2006.16.1251.
7
Diagnosis of Resistance to Thyroid Hormone due to a Rare Mutation in the Thyroid Hormone Receptor Beta Gene in a Patient Previously Presumed to Have Graves' Disease.诊断因甲状腺激素受体β基因罕见突变导致的甲状腺激素抵抗,该患者先前被误诊为格雷夫斯病。
Mil Med. 2024 Jan 23;189(1-2):e439-e442. doi: 10.1093/milmed/usad283.
8
Characteristics of patients with late manifestation of resistance thyroid hormone syndrome: a single-center experience.甲状腺激素抵抗综合征晚期表现患者的特征:单中心经验
Endocrine. 2015 Dec;50(3):689-97. doi: 10.1007/s12020-015-0622-x. Epub 2015 Jun 4.
9
Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.尽管促甲状腺激素结合抑制性免疫球蛋白检测结果迅速转阴,但仍存在持续性格雷夫斯甲亢:一例报告
J Med Case Rep. 2017 Feb 6;11(1):32. doi: 10.1186/s13256-017-1214-6.
10
Elevated serum granulocyte colony-stimulating factor levels in patients with Graves' disease.格雷夫斯病患者血清粒细胞集落刺激因子水平升高。
Clin Endocrinol (Oxf). 1998 Mar;48(3):275-80. doi: 10.1046/j.1365-2265.1998.00422.x.

引用本文的文献

1
Effective TRIAC treatment of a THRβ-mutated patient with thyroid hormone resistance.甲状腺激素抵抗患者中 THRβ 突变经 TRIAC 治疗有效。
Endocrine. 2024 Aug;85(2):598-600. doi: 10.1007/s12020-024-03795-3. Epub 2024 Apr 1.
2
Central hyperthyroidism combined with Graves' disease: case series and review of the literature.中枢性甲亢合并 Graves 病:病例系列及文献复习。
Eur Thyroid J. 2023 Jul 28;12(4):e220223. doi: 10.1530/ETJ-22-0223.
3
Resistance to Thyroid Hormone Beta: A Focused Review.抗甲状腺激素β受体:专题述评。
Front Endocrinol (Lausanne). 2021 Mar 31;12:656551. doi: 10.3389/fendo.2021.656551. eCollection 2021.
4
Coexistence of Autoimmune Hyper- and Hypothyroidism in a Kindred with Reduced Sensitivity to Thyroid Hormone.甲状腺激素敏感性降低的家族中自身免疫性甲状腺功能亢进与减退并存。
Eur Thyroid J. 2020 Sep;9(5):263-268. doi: 10.1159/000506424. Epub 2020 Apr 17.
5
Painless destructive thyroiditis in a patient with resistance to thyroid hormone: a case report.甲状腺激素抵抗患者的无痛性破坏性甲状腺炎:一例报告
Thyroid Res. 2019 Oct 25;12:8. doi: 10.1186/s13044-019-0072-2. eCollection 2019.
6
Genomic test ends a long diagnostic odyssey in a patient with resistance to thyroid hormones.基因检测终结了一名甲状腺激素抵抗患者漫长的诊断之旅。
Thyroid Res. 2019 Jul 15;12:7. doi: 10.1186/s13044-019-0068-y. eCollection 2019.
7
Mutational Landscape of Resistance to Thyroid Hormone Beta (RTHβ).β 型甲状腺激素抵抗突变体的突变谱
Mol Diagn Ther. 2019 Jun;23(3):353-368. doi: 10.1007/s40291-019-00399-w.
8
Graves' disease coexisting with resistance to thyroid hormone: a rare case.格雷夫斯病合并甲状腺激素抵抗:1例罕见病例。
Clin Case Rep. 2017 Dec 29;6(2):337-341. doi: 10.1002/ccr3.1344. eCollection 2018 Feb.
9
A Novel Thyroid Hormone Receptor Beta Gene Mutation (G251V) in a Thai Patient with Resistance to Thyroid Hormone Coexisting with Pituitary Incidentaloma.一名泰国甲状腺激素抵抗患者中一种新的甲状腺激素受体β基因突变(G251V)与垂体意外瘤共存
Thyroid. 2016 Dec;26(12):1804-1806. doi: 10.1089/thy.2016.0450. Epub 2016 Oct 31.